Engineered anti-TSLP antibody

Details for Australian Patent Application No. 2007334499 (hide)

Owner SCHERING CORPORATION

Inventors Presta, Leonard G.; De Waal Malefyt, Rene

Agent Griffith Hack

Pub. Number AU-A-2007334499

PCT Pub. Number WO2008/076321

Priority 60/869,974 14.12.06 US

Filing date 13 December 2007

Wipo publication date 26 June 2008

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C12N 5/18 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Murine cells, e.g. mouse cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/076321 Priority application(s): WO2008/076321

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007334502-Compositions and methods to treat muscular & cardiovascular disorders

2007334495-Useful life indicators